0001415889-21-004258.txt : 20210903
0001415889-21-004258.hdr.sgml : 20210903
20210903214945
ACCESSION NUMBER: 0001415889-21-004258
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210902
FILED AS OF DATE: 20210903
DATE AS OF CHANGE: 20210903
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cozzens Todd C
CENTRAL INDEX KEY: 0001382487
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 211238106
MAIL ADDRESS:
STREET 1: ONE FEDERAL STREET
STREET 2: 25TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-09032021_060935.xml
X0306
4
2021-09-02
0001604821
Natera, Inc.
NTRA
0001382487
Cozzens Todd C
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
true
false
false
false
Common Stock
2021-09-02
4
M
0
2733
1.3855
A
15723
D
Common Stock
2021-09-02
4
M
0
11169
11.80
A
26892
D
Common Stock
2021-09-02
4
M
0
10578
10.41
A
37470
D
Common Stock
2021-09-02
4
S
0
8841
120.9623
D
28629
D
Common Stock
2021-09-02
4
S
0
10666
121.9634
D
17963
D
Common Stock
2021-09-02
4
S
0
4764
122.7058
D
23865
D
Stock Option (right to buy)
1.3855
2021-09-02
4
M
0
2733
0
D
2023-04-17
Common Stock
2733
0
D
Stock Option (right to buy)
11.80
2021-09-02
4
M
0
11169
0
D
2026-06-09
Common Stock
11169
0
D
Stock Option (right to buy)
10.41
2021-09-02
4
M
0
10578
0
D
2027-06-08
Common Stock
10578
591
D
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.42 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.50 to $122.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.50 to $123.1050 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option shares vested fully and became exercisable on March 21, 2021.
The option shares vested fully and became exercisable on May 23, 2017.
The option shares vested fully and became exercisable on May 16, 2018.
/s/ Tami Chen, Attorney-in-Fact
2021-09-03